Human papillomavirus infection: An old disease, a new vaccine

Michelle Giles, Suzanne Garland

Research output: Contribution to journalReview ArticleResearchpeer-review

11 Citations (Scopus)


Human papillomavirus (HPV) infection is common and causes a wide spectrum of disease. With recent advances in the development of prophylactic HPV vaccines, it is likely that these will be licensed for use in the near future. This review focuses on the science behind HPV vaccines, published clinical trial results for both prophylactic and therapeutic HPV vaccines, important issues relevant to implementation and cost-effectiveness models of HPV vaccination programs. It may be that an HPV vaccine that protects against the complications of HPV infection such as cervical cancer will be one of the most significant public health initiatives of this decade.

Original languageEnglish
Pages (from-to)180-185
Number of pages6
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Issue number3
Publication statusPublished - 1 Jun 2006
Externally publishedYes


  • Cervical cancer
  • Human papillomavirus
  • Vaccine

Cite this